Results 111 to 120 of about 320,100 (253)

Congenital Heart Defects: CDC\u2019s Tracking and Research Activities

open access: yes
CDC works to better understand how often and why congenital heart defects (CHDs) occur, and the characteristics and health outcomes, use of services, and racial/ethnic differences of people living with CHDs. By learning more about those living with CHDs,

core  

Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices

open access: yesESC Heart Failure
Aims No curative treatment is available for RASopathy‐associated childhood‐onset hypertrophic cardiomyopathy (RAS‐CM). Preclinical data and individual reports suggest a beneficial effect of small molecules targeting the RAS–mitogen‐activated protein (MAP)
Jules Hamers   +11 more
doaj   +1 more source

Congenital heart defects in Kabuki syndrome

open access: yes, 2013
Background: Kabuki syndrome (KS) is an entity of multiple congenital malformations withmental retardation with undetermined etiology. Congenital heart defects are one of the clinicalmanifestations of KS with insuffi cient elucidations.Methods: Literature
Yuan, Shi-Min; The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, China
core   +1 more source

5 Things To Know About Heart Defects

open access: yes
Heart defects are conditions that are present at birth and can affect the structure of a person\u2019s heart and the way it works. Heart defects are common, costly, and critical conditions that affect people throughout their lives.

core  

Amplatzer occluders – a breakthrough in the interventional treatment of congenital heart defects. 27 years of experience

open access: yes
This review synthesizes the experience of a single institution in the percutaneous closure of the most common congenital heart defects – atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA) – using Amplatzer ...
Jacek Białkowski, Małgorzata Szkutnik
core   +1 more source

Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability

open access: yesEuropean Journal of Human Genetics, 2018
Rosalind Verheije   +43 more
semanticscholar   +1 more source

Juxtaposition of the atrial appendages in a patient with a simple ventricular septal defectCentral Message

open access: yesJTCVS Techniques, 2021
Julie Cleuziou, MD, PhD, MBA   +3 more
doaj   +1 more source

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy

open access: yesScientific Reports
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes coding for structural sarcomeric proteins, is the most common inherited heart disease.
Sarala Raj Murthi   +30 more
doaj   +1 more source

Epidemiology of congenital heart defects in France from 2013 to 2022 using the PMSI-MCO (French Medical Information System Program in Medicine, Surgery, and Obstetrics) database.

open access: yesPLoS ONE
BackgroundCongenital heart defects are common and occur in approximately 0.9% of births. In France, the registries cover approximately 20% of the population but not the entirety of France; therefore, we aimed to update the incidence data for congenital ...
Gurvan Bourdon   +7 more
doaj   +1 more source

Intraoperative sodium range affects white matter microstructure in neonatal congenital heart disease

open access: yesInternational Journal of Cardiology Congenital Heart Disease
Background: Intraoperative sodium changes and new postoperative white matter injury are prevalent in neonates with congenital heart disease (CHD) who undergo cardiopulmonary bypass surgery. Rapid sodium correction in hyponatremia is associated with white
Mirthe E.M. van der Meijden   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy